Navigation Links
Zebra Technologies Enters Into Revolving Credit Agreement to Support Company Growth

VERNON HILLS, Ill., Aug. 15 /PRNewswire-FirstCall/ -- Zebra Technologies Corporation (Nasdaq: ZBRA) today announced that it has entered into a five-year, $100 million revolving credit facility. Zebra will be able to draw upon the credit facility for working capital and general corporate purposes, including stock buybacks and acquisitions. The revolving credit facility has a $100 million accordion feature that allows the company to increase the facility up to a total of $200 million subject to obtaining commitments for the incremental capacity from existing or new lenders.

"We put the credit facility in place to provide financing flexibility," stated Michael Smiley, Zebra's chief financial officer. "Zebra's ability to secure credit on favorable terms in this uncertain financial market environment is a testament to the strength of the company's balance sheet, cash flows and growth prospects."

The lead arranger and book runner for the new credit facility is J.P. Morgan Securities Inc., with Northern Trust Co. as the syndication agent, Bank of America, N.A. as the documentation agent and JPMorgan Chase Bank, N.A. as the administration agent. Also included in the facility allocation are Wells Fargo Bank, N.A. and RBS Citizens, N.A.

Zebra Technologies Corporation helps companies identify, locate and track assets, transactions and people with on-demand specialty digital printing and automatic identification solutions. In more than 100 countries around the world, more than 90 percent of Fortune 500 companies use innovative and reliable Zebra printers, supplies, RFID products and software to increase productivity, improve quality, lower costs, and deliver better customer service. Information about Zebra and Zebra-brand products can be found at


Investors: Financial Media:

Douglas A. Fox, CFA Tim Dreyer

VP, Investor Relations Manager, Public Relations

+1 847 793 6735 +1 847 793 5677

SOURCE Zebra Technologies Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology news :

1. Deadly genetic disease prevented before birth in zebrafish
2. A screening strategy using zebrafish targets genes that protect against hearing loss
3. New map outlines risk of zebra mussel invasion
4. New national map shows relative risk for zebra and quagga mussel invasion
5. Study shows how the zebrafish gets his stripe
6. Zebrafish to shed light on human mitochondrial diseases
7. Integrated Fuel Technologies gets worldwide license for Argonne-developed Diesel DeNOx Catalyst
8. Pitt faculty receive awards to explore next-generation technologies
9. OSU technologies funded for development
10. CrimeCog Technologies Unveils Enhanced JMS Module of E*JUSTICE SYSTEMS(TM)
11. Oberthur Technologies XPon Offer
Post Your Comments:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/22/2016)... 22, 2016 According ... Market for Consumer Industry by Type (Image, Motion, ... (Communication & IT, Entertainment, Home Appliances, & ... to 2022", published by MarketsandMarkets, the market ... reach USD 26.76 Billion by 2022, at ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
(Date:6/23/2016)... 23, 2016 adds ... to its pharmaceuticals section with historic and forecast ... much more. Complete report on the ... profiling 15 companies and supported with 261 tables ... . The Global Cell Culture ...
Breaking Biology Technology: